Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > "I read for amusement only" really pal?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by georgesoreloseon Feb 07, 2017 7:53pm
334 Views
Post# 25813557

"I read for amusement only" really pal?

"I read for amusement only" really pal?I invest for "amusement only"

I was quite thrilled to buy at $96.50 with a "top pick" and $104.00 target

I ws even more "amused" at the "Seeking Alpha Sidecar"..."Death Blow" article..amusing

Amusement my azz...the goal here is to misleead and deceive and check the mirror pal.

Sick...the RCMP will begin to clamp down hard on these "Bio-tech Blunders"

Watch close pal
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities